Core Insights - The Chinese medical beauty market is experiencing a significant shift in 2025, marked by a 93.40% growth in the regenerative filling materials sector, but with notable disparities among brands [1][2] - The "Matthew Effect" is becoming evident, where leading brands are gaining market share at the expense of smaller competitors, particularly in the context of regulatory barriers and technological advancements [1][10] Regenerative Filling Materials - Regenerative filling materials have emerged as the "MVP" of the year, with a 93.40% increase in sales in 2025, continuing a trend of rapid growth over the past three years [2] - The brand "Zhenai Su Fei" under Aimeike leads with a remarkable 463% growth, while "Yiyan Shi" from Huadong Pharmaceutical, once a market leader, has seen a 56% decline [2][3] - Despite the growth of "Zhenai Su Fei," its contribution to Aimeike's overall performance remains uncertain, as the company reported over a 20% decline in revenue and net profit in the first three quarters of 2025 [2] Market Dynamics - The decline of "Yiyan Shi" is attributed to its earlier market entry leading to reduced novelty among consumers, and some users seeking alternative products after initial experiences [3] - The market for ultrasonic devices, once a star in anti-aging treatments, has seen a 55.2% drop in sales, indicating a shift in consumer preferences and budget constraints [4][8] - In contrast, the "Meila Meisheng" ultrasonic knife has gained popularity, with a 147.22% increase in sales, appealing to users aged 35 and above [4][5] Competitive Landscape - The competitive landscape is tightening, with head brands further squeezing the market space for smaller brands, as consumers tend to prefer established, reliable products [4] - The decline in ultrasonic device sales is not solely due to the emergence of new technologies but also reflects market misuse and consumer fatigue [7][10] Hyaluronic Acid Market - Hyaluronic acid remains a top-selling product, with a 19.70% increase in sales in 2025, despite facing challenges such as oversupply and intense price competition [8][9] - The product's versatility and ability to cater to a wide range of consumer needs contribute to its sustained popularity, positioning it as a mainstay in the anti-aging market [9] Future Growth Areas - The market is transitioning towards specialized segments, with a focus on individual needs and the emergence of new growth areas such as recombinant collagen products, hair loss treatments, and weight management [10][11] - The recombinant collagen market is projected to grow at a compound annual growth rate of 41.4% from 2023 to 2027, indicating strong potential for expansion [10]